{"id":391548,"date":"2014-09-22T00:00:00","date_gmt":"2014-09-22T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/latrim0614-biopharma-entyvio-wave-1-launchtrends-us-2014\/"},"modified":"2026-03-31T09:04:40","modified_gmt":"2026-03-31T09:04:40","slug":"latrim0614-biopharma-entyvio-wave-1-launchtrends-us-2014","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/latrim0614-biopharma-entyvio-wave-1-launchtrends-us-2014\/","title":{"rendered":"Entyvio (Wave 1) | LaunchTrends | US | 2014"},"content":{"rendered":"<p>Takeda\u2019s Entyvio (vedolizumab) gained FDA approval in May 2014; the drug launched in the United States in June 2014. This report measures the impact of this novel agent on the moderate to severe ulcerative colitis (UC) and Crohn\u2019s disease (CD) market following launch. The report evaluates physicians\u2019 current awareness and familiarity with Entyvio, the advantages and disadvantages compared to currently available therapies, and the current and anticipated usage of the drug; as well as the drug\u2019s promotional activity.<\/p>\n","protected":false},"template":"","class_list":["post-391548","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-crohns-disease","biopharma-geography-us","biopharma-date-574"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391548","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391548\/revisions"}],"predecessor-version":[{"id":394671,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/391548\/revisions\/394671"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=391548"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}